Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Gains from Investment Securities (2016 - 2026)

Dexcom has reported Gains from Investment Securities over the past 16 years, most recently at $1.5 million for Q1 2026.

  • Quarterly Gains from Investment Securities rose 36.36% to $1.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Mar 2026, down 62.38% year-over-year, with the annual reading at $19.2 million for FY2025, 60.57% down from the prior year.
  • Gains from Investment Securities was $1.5 million for Q1 2026 at Dexcom, down from $17.8 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $36.9 million in Q4 2024 and troughed at -$46.8 million in Q4 2022.
  • The 5-year median for Gains from Investment Securities is $1.5 million (2026), against an average of $3.2 million.
  • Year-over-year, Gains from Investment Securities crashed 360.0% in 2022 and then skyrocketed 688.89% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at -$46.8 million in 2022, then skyrocketed by 38.46% to -$28.8 million in 2023, then surged by 228.12% to $36.9 million in 2024, then tumbled by 51.76% to $17.8 million in 2025, then crashed by 91.57% to $1.5 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Gains from Investment Securities are $1.5 million (Q1 2026), $17.8 million (Q4 2025), and $900000.0 (Q3 2025).